FALLS CHURCH, Va., Sept. 10, 2019 /PRNewswire-PRWeb/ -- Drug Regulation in China Updates,
If business is currently being done in China or being considered in the China market, this is a must-attend webinar.
Recent reforms coupled with seemingly ever-changing drug regulations makes navigating the drug regulatory lifecycle in China quite the challenge. It significantly impacts pharmaceutical companies doing business there or looking to enter the China market.
John Balzano, Esq., a partner at Covington & Burling LLP with over a decade of experience in legal and regulatory issues related to healthcare products and services in China, will provide one with valuable insights on:
This is the opportunity to understand the recent developments in drug regulation in China and make them work for the business.
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: Drug Regulation in China Updates, Key Issues and Common Challenges An FDAnews Webinar Tuesday, Sept. 24, 2019, 1:30-3:00 p.m. EDT https://www.fdanews.com/drugregchina
Tuition: $287 per site
Easy Ways to Register: Online: fdanews.com/drugregchina?hittrk=1991VOCUS https://www.fdanews.com/drugregchina By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Subscribe to our Free Newsletters!